Clinical Trials Directory

Trials / Unknown

UnknownNCT04018144

Running Title: PPAR-γ, RXR-α, and VDR Expressions in Periodontitis

PPAR-γ, RXR-α, and VDR Expressions in Periodontitis Patients With Different Stage and Grade Involvement

Status
Unknown
Phase
Study type
Observational
Enrollment
45 (estimated)
Sponsor
Tokat Gaziosmanpasa University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Objective: The present study aimed to determine the expressions of nuclear receptors PPAR (Peroxisome proliferative activator receptor)-γ, RXR (Retinoid X receptor)-α, and vitamin D receptor (VDR) in healthy volunteers and periodontitis patients with different grade involvement. Methods: Group-1; healthy individuals, Group-2; periodontitis patients-stage 3 grade B, (H-GradeB), Group-3; periodontitis patients-stage 3 grade C, (D-GradeC). Clinical parameters as plaque index (PI), gingival index (GI) and clinical attachment levels (CAL) were measured. Fibroblast and inflammatory cells, PPAR-γ, RXR-α, and VDR levels were determined in histological slides.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGingiva Biopsy SamplingGingival samples of healthy individuals were collected by gingivectomy or crown lengthening procedure in the routine treatment protocol or before orthodontically indicated tooth extraction. Gingival samples of periodontitis patients were obtained during the scaling and root planning procedure. Posterior maxillary teeth (#4, #5, #6, and #7) were chosen for gingival sampling.

Timeline

Start date
2019-08-01
Primary completion
2019-12-01
Completion
2020-03-01
First posted
2019-07-12
Last updated
2019-07-12

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04018144. Inclusion in this directory is not an endorsement.